Author details

Full Name

Lori M Laffel

Affiliation

ORCID

Career Start Year

1988

Papers

292

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35343269	Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study.	J Diabetes Sci Technol	2023
36066457	Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.	Endocrine Reviews	2023
35725290	Celebration of a century of insulin therapy in children with type 1 diabetes.	Archives of Disease in Childhood	2023
36412631	Long-Term Retention of Young Adult Study Participants with Youth-Onset Type 2 Diabetes: Results from the TODAY2 Study.	Hormone Research in Paediatrics	2023
36184368	Assessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes and Personal Treatment (ADAPT) Survey in Teens and Young Adults.		2023
35466707	Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes.	Journal of diabetes science and technology	2023
37733932	Correction to "Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring".		2023
37583558	School Nurses' Comfort With Diabetes Management and Technology From 2012 to 2019.		2023
37794253	Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.	Nat Med	2023
37794113	Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review.		2023
36912009	Updated Psychosocial Surveys With Continuous Glucose Monitoring Items for Youth With Type 1 Diabetes and Their Caregivers.		2023
37471606	The Growing Role of Technology in the Care of Older Adults With Diabetes.	Diabetes Care	2023
37209705	From paediatric to adult diabetes care: lost in transition.		2023
37083018	Twelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes.		2023
36824050	A Randomized Pilot Trial Using Mobile Health and Financial Incentives to Motivate Heart-Healthy Behaviors in Adolescents With Type 1 Diabetes.		2023
36818409	Associations of Executive Function With Diabetes Management and Glycemic Control in Adolescents With Type 1 Diabetes.		2023
36493795	Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.		2023
37434027	Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study.		2023
37292813	Insights from rare variants into the genetic architecture and biology of youth-onset type 2 diabetes.	Res Sq	2023
34330178	Ecological Momentary Assessment of Positive and Negative Affect and Associations with Blood Glucose in Teens with Type 1 Diabetes.	Journal of diabetes science and technology	2023
35043720	Development of a Novel Insulin Sensor for Clinical Decision-Making.	Journal of diabetes science and technology	2023
35118893	Clinical Evaluation of a Novel Insulin Immunosensor.	Journal of diabetes science and technology	2023
34652236	Observed Characteristics Associated with Diabetes Device Use Among Teens with Type 1 Diabetes.	Journal of diabetes science and technology	2023
35099294	Insulin Delivery and Glucose Variability Throughout the Menstrual Cycle on Closed Loop Control for Women with Type 1 Diabetes.	Diabetes Technology and Therapeutics	2022
35715001	Concept of the "Universal Slope": Toward Substantially Shorter Decentralized Insulin Immunoassays.	Analytical Chemistry	2022
35658634	Health Disparities Likely Emerge Early in the Course of Type-1 Diabetes in Youth.	Journal of diabetes science and technology	2022
35971681	Feasibility and Preliminary Safety of Smartphone-Based Automated Insulin Delivery in Adolescents and Children With Type 1 Diabetes.	Journal of diabetes science and technology	2022
35653647	Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring.	Analytical Chemistry	2022
36102751	Commercially Available Insulin Products Demonstrate Consistency With Product Labeling Throughout All Seasons in the U.S.	Diabetes Care	2022
35446449	Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes.	Pediatric Diabetes	2022
35380233	Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes.	Diabetologia	2022
35948357	Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.	Journal of Clinical Endocrinology and Metabolism	2022
35378069	Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.	Lancet Diabetes and Endocrinology,The	2022
36082016	Acquisition of Self-Care Responsibility in Youth With Type 1 Diabetes: Opportunities for Improving Tailored Diabetes Education and Support Programs.	Diabetes Spectrum	2022
36001755	Health Care Utilization Trends Across the Transition Period in a National Cohort of Adolescents and Young Adults With Type 1 Diabetes.	Diabetes Care	2022
35549708	Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4.	Diabetes Technology and Therapeutics	2022
35853530	How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the OmnipodÂ® 5 System.	Diabetes Research and Clinical Practice	2022
35718691	Assessing Diabetes Distress in Emerging Adults With Type 1 Diabetes: Development and Validation of the Problem Areas in Diabetes-Emerging Adult Version.		2022
36992759	Caring for Young Adults With Diabetes in the Adult Care Setting: Summary of a Multidisciplinary Roundtable.		2022
36537528	ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring.		2022
34524008	Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes During 1 Year of the COVID-19 Pandemic.	Diabetes Technology and Therapeutics	2022
34605694	Continuous Ketone Monitoring Consensus Report 2021.	J Diabetes Sci Technol	2022
34922687	Sodium-Glucose Transporter Inhibition in Adult and Pediatric Patients with Type 1 Diabetes Mellitus.	Advances in Chronic Kidney Disease	2021
34115959	Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial.	Diabetes Technology and Therapeutics	2021
33794006	Cost considerations for adoption of diabetes technology are pervasive: A qualitative study of persons living with type 1 diabetes and their families.	Diabetic Medicine	2021
34273197	Association of executive function problems and disordered eating behaviours in teens with type 1 diabetes.	Diabetic Medicine	2021
34270328	Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives.	Diabetes Technology and Therapeutics	2021
34099518	Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.	Diabetes Care	2021
34031003	Blood glucose monitoring (BGM) still matters for many: Associations of BGM frequency and glycemic control in youth with type 1 diabetes.		2021
34027090	A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control.	Bioengineering and Translational Medicine	2021